Additional file 2: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

  • Cheng Maw Ho (Contributor)
  • Chih-hsin Lee (Contributor)
  • Ming-Chia Lee (Contributor)
  • Jun Fu Zhang (Contributor)
  • Jann Yuan Wang (Contributor)
  • Rey Heng Hu (Contributor)
  • Po-Huang Lee (Contributor)

Dataset

Description

List of HBV and HCV medications, diagnostic criteria of liver cirrhosis, hyperlipidemia, and alcohol consumption. (DOCX 18 kb)
Date made availableApr 10 2018
PublisherUnknown Publisher

Cite this